Niagara Falls, ON

Join us in spectacluar Niagara Falls, ON for 3 days of cannabis cultivation, psychedelics and extraction.

September 11-13, 2022

Grow Up Awards Gala

Annual Grow Up Industry Awards. Come celebrate the innovation and sucess in the cannabis growing industry.

September 12, 2022, Niagara Falls

U.S. federal government invests nearly $1.8 million to track how cannabis compounds change in a person’s breath over time

Aug 8, 2022 | Media Partners, The GrowthOp

This post is presented by our media partner The Growth Op
View the original article here.

“Currently, it is impossible to draw a correlation between driving impairment and [THC] concentration in blood, which is the most reliable matrix with which to determine recent cannabis use”

Article content

The U.S. federal government is investing more money into creating roadside testing methods capable of detecting recent cannabis use.

Advertisement 2

Story continues below

Article content

The National Institute of Science and Technology has posted a notice for assistance on a study that would test breath and blood samples for cannabinoids, reports Marijuana Moment.

  1. The police service has now deployed the new roadside screening devices for THC across the territory. /

    N.W.T. RCMP deploys new roadside screening device for THC

  2. FILE: The Ottawa Police Service conducts MEGA Ride at Innes Road on Oct. 18, 2018. /

    New study points to a replacement for cannabis breathalyzers

  3. Simulator measured common driving variables, such as swerving in the lane, responding to divided attention tasks and following a lead car. /

    Weed smokers and placebo takers show same driving performance after four hours

The agency is operating with a budget of more than US$1.4 million (about $1.8 million) for the study.

“Cannabis induces executive function deficits that make drivers more likely to be involved in crashes than unimpaired drivers, yet, to date, there is no means to chemically detect impairment at the roadside,” notes a funding summary for the study.

Advertisement 3

Story continues below

Article content

“Currently, it is impossible to draw a correlation between driving impairment and [THC] concentration in blood, which is the most reliable matrix with which to determine recent cannabis use,” it adds.

The funding is part of a larger package announced by the National Institute of Justice (NIJ) last year. More than US$14 million ($17.9 million) was allocated to support 30 forensic science research and development projects.

“With these awards, NIJ continues its dedication to strengthening the criminal justice system through forensic science research and development,” Lucas Zarwell, director of NIJ’s Office of Investigative and Forensic Sciences, said when that funding was announced.

“We appreciate all the innovative and dedicated scientists who are committed to increasing our understanding of, or producing useful technologies for, the forensic sciences,” Zarwell noted at the time.

Advertisement 4

Story continues below

Article content

The upcoming study, Breath Measurements of Acute Cannabis Elimination, or BACE, proposes collecting breath samples between short intervals to track how cannabis compounds change in a person’s breath over time.

“We will investigate the feasibility of a two-point measurement that could be implemented at the roadside. We propose to collect breath samples from occasional and frequent cannabis users at 10-minute intervals during acute cannabis elimination, similar to the previous work, and during periods of abstinence, which has not been examined,” the funding award explains.

Last month, the Northwest Territories RCMP deployed a new tool designed to determine if drivers are over the legal limit for cannabis.

Advertisement 5

Story continues below

Article content

The RCMP report the devices are used to take an oral fluid sample, can be completed in about 15 minutes and are similar to roadside alcohol tests.

Under the federal Cannabis Act, testing at or over two nanograms (ng), but under 5 ng, of THC per millilitre (ml) of blood, is a summary conviction offence punishable by a maximum fine of $1,000. Drivers who test over 5 ng of THC per ml of blood face minimum penalties of $1,000 fine for a first offence, 30 days imprisonment for a second offence and 120 days imprisonment for a third offence.

“In the N.W.T., there is zero tolerance for alcohol and drugs for drivers 21 and under, novice drivers and some commercial vehicle drivers,” notes the Northwest Territories Liquor and Cannabis Commission.

Advertisement 6

Story continues below

Article content

A study published earlier this year in JAMA Psychiatry found that regular cannabis consumers taking part in simulated driving testing saw reduced skills behind the wheel, but “indistinguishable” performance at 4.5 hours compared to those taking a placebo.

Researchers at Massachusetts General Hospital proposed another non-invasive measure for detecting cannabis impairment earlier this year by using functional near-infrared spectroscopy, which measures brain patterns, and correlating the readings to THC impairment.

Published in Neuropsychopharmacology, the study found that those who consumed cannabis showed higher levels of neural activity in the prefrontal cortex of the brain when compared to those given a placebo.

Advertisement 7

Story continues below

Article content

“Our research represents a novel direction for impairment testing in the field,” said lead author Jodi Gilman, associate professor at Harvard University and an investigator in the Center for Addiction Medicine.

“Our goal was to determine if cannabis impairment could be detected from activity of the brain on an individual level. This is a critical issue because a breathalyzer-type of approach will not work for detecting cannabis impairment, which makes it very difficult to objectively assess impairment from THC during a traffic stop,” Gilman pointed out.

Yet another 2022 study, this time out of Australia, found that “higher blood THC concentrations were only weakly associated with increased impairment in occasional cannabis users, while no significant relationship was detected in regular cannabis users.”

“This suggests that blood and oral fluid THC concentrations are relatively poor indicators of cannabis-THC-induced impairment,” the study authors concluded.

Subscribe to Weekend Dispensary, a weekly newsletter from The GrowthOp.

Advertisement 1

Story continues below

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

This post was originally published by our media partner here.

Grow Up – September 11-13, 2022
Niagara Falls Convention Centre, ON